PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead
PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead underwriter will be CS First Boston. CTI had annual revenues of $188.9 million and net income of $6.4 million in fiscal 2001, which ended Sept. 30. The company employs 620 full- and part-time staff, according to WSRN.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.